Luke Beshar
Chairman en PROTARA THERAPEUTICS, INC. .
Fortuna: 793 980 $ al 31/03/2024
Perfil
Luke M.
Beshar is currently the Chairman at Inotrem SA, Chairman at Protara Therapeutics, Inc., Director at Fluorinov Pharmaceuticals, Inc., Independent Director at Omega Therapeutics, Inc., and Member at New York State Society of Certified Public Accountants.
Previously, he served as Chairman at Entera Bio Ltd.
from 2016 to 2018, Chairman at ArTara Subsidiary, Inc., Director at PNY Technologies, Inc., Independent Director at Trillium Therapeutics ULC from 2014 to 2021, Independent Director at REGENXBIO, Inc. from 2015 to 2021, Director at Sancilio & Co., Inc., Director at Sancilio Pharmaceuticals Co., Inc., Chief Financial Officer & Executive Vice President at Cambrex Corp.
from 2002 to 2007, Chief Financial Officer at The Genlyte Group, Inc., Chief Financial Officer & Executive Vice President at NPS Pharmaceuticals, Inc. from 2012 to 2015, Chief Financial Officer & Senior Vice President at Dendrite International, Inc. in 2002, Chief Financial Officer at WSR Corp, and Chief Financial Officer & Executive Vice President at Exp@nets, Inc. from 1998 to 2002.
Mr. Beshar obtained his undergraduate degree from Michigan State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 07/06/2023 | 198 000 ( 1.73% ) | 793 980 $ | 31/03/2024 | |
OMEGA THERAPEUTICS, INC.
-.--% | 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Luke Beshar
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Chairman | 01/01/2020 |
| OMEGA THERAPEUTICS, INC. | Director/Board Member | 01/05/2021 |
New York State Society of Certified Public Accountants
 New York State Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services New York State Society of Certified Public Accountants is a non-profit organization. It provides a membership program for certified public accountants that offers in-person and online networking opportunities, Continuing Professional Education courses and conferences, the CPA Journal, and other publications. The company was foudned in 1897 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Fluorinov Pharmaceuticals, Inc.
 Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Director/Board Member | 26/05/2015 |
Inotrem SA
 Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Chairman | - |
Antiguos cargos conocidos de Luke Beshar.
| Empresas | Cargo | Fin |
|---|---|---|
| TRILLIUM THERAPEUTICS | Director/Board Member | 17/11/2021 |
| REGENXBIO INC. | Director/Board Member | 03/09/2021 |
| ENTERA BIO LTD. | Chairman | 06/08/2018 |
| NPS PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/02/2015 |
| ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Luke Beshar.
| Michigan State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| REGENXBIO INC. | Health Technology |
| ENTERA BIO LTD. | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 14 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
The Genlyte Group, Inc.
 The Genlyte Group, Inc. Electrical ProductsProducer Manufacturing The Genlyte Group, Inc. designs and manufactures indoor and outdoor lighting products for the incandescent, fluorescent, emergency, high-intensity discharge (HID), down lighting, medical and commercial decorative lighting and niche markets. The company is headquartered in Burlington, MA. | Producer Manufacturing |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Dendrite International, Inc.
 Dendrite International, Inc. Packaged SoftwareTechnology Services Dendrite International, Inc. provides sales force software products and support services. It offers technological tools, databases, and data flow management services. The company provides services to the pharmaceutical, life sciences, and healthcare industries. Dendrite International was founded by John E. Bailye in 1986 and is headquartered in Bedminster, NJ. | Technology Services |
PNY Technologies, Inc.
 PNY Technologies, Inc. Computer PeripheralsElectronic Technology PNY Technologies, Inc. manufactures and supplies computer graphic accelerator cards. It provides graphic cards, solid state drives, PC memory, USB, OTG, flash memory cards, and XLR8 gaming products. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Electronic Technology |
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
WSR Corp
 WSR Corp Specialty StoresRetail Trade WSR Corp is a private company that owns and operates auto supply stores. The company is based in Glenview, IL. | Retail Trade |
New York State Society of Certified Public Accountants
New York State Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services New York State Society of Certified Public Accountants is a non-profit organization. It provides a membership program for certified public accountants that offers in-person and online networking opportunities, Continuing Professional Education courses and conferences, the CPA Journal, and other publications. The company was foudned in 1897 and is headquartered in New York, NY. | Commercial Services |
| Exp@nets, Inc. | |
Sancilio & Co., Inc.
 Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL. | Commercial Services |
Fluorinov Pharmaceuticals, Inc.
Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Health Technology |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Health Technology |
Sancilio Pharmaceuticals Co., Inc.
 Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Commercial Services |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Luke Beshar
